MeSH D002318 - cardiovascular diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Organon | Alendronic acid, Cholecalciferol | Fosamax D |  | 2005-04-07 |  |  |
| Alendronic acid, Cholecalciferol | Adrovance |  | 2007-01-04 |  |  | |
| Alendronic acid, Cholecalciferol | Fosavance |  | 2005-08-24 |  |  | |
| Alendronic acid, Cholecalciferol | Vantavo (previously Alendronate colecalciferol, MSD) |  | 2009-10-16 |  |  | |
| Sandoz | Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Phytonadione, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol | Infuvite |  | 2000-05-18 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
66%41/62
Phase 2
76%84/110
Phase 3
41%68/164
Approved: 3Overall Success rate: 21%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use